Wartime powers enacted to address nationwide IV fluid shortage

The wartime powers provision of the Defense Production Act have been invoked to address a growing shortage of IV fluids and supplies caused by damage to a Baxter production facility in North Cove, North Carolina. 

The damage from Hurricane Helene was extensive to North Cove and the broader Asheville region, with heavy floods contaminating manufacturing equipment and washing out roads, leaving the Baxter plant nonoperational. 

Recovery is underway. However, as the Baxter facility produces 60% of the IV bags used in the U.S., competitors have been unable to keep up with the supply chain disruption. 

The Biden administration said it is using wartime powers to get the facility back to full capacity and to ramp up alternative means of production. CBS News was the first to report the news, citing an official with the Department of Health and Human Services (HHS).

"Ensuring people have medical supplies they need is a top priority of the Administration. It's exactly why we are working closely with Baxter to support cleanup and restoration of the facility, including invoking the Defense Production Act to help production resume as quickly as possible," the HHS official told the outlet. 

The U.S. Food and Drug Administration (FDA) recognized the shortages last week, with extra emphasis placed on seven IV fluids, including dextrose, sodium chloride, sterile water and dialysis fluids. 

With FDA approval, Baxter announced it has begun importing IV fluids from its international plants in Canada, China, the U.K. and Ireland. The company also said it's released any stored products remaining in inventory, after ensuring they were safe for use in a hospital setting. 

At present, a survey from group purchasing organization Premier estimates 86% of providers are experiencing IV fluid shortages. The FDA and Baxter both have recommended rationing available IV bags to prioritize critical and pediatric patients until supplies stabilize.

Baxter is providing regular updates on the status of the North Cove plant on its website, which you can find here.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”